首页> 外国专利> CELL MODEL BASED ON STAT3 AND NF-ĸB DUAL-SIGNALLING PATHWAY AS TARGET FOR SCREENING ANTI-TUMOUR DRUG AND CONSTRUCTION AND USE THEREOF

CELL MODEL BASED ON STAT3 AND NF-ĸB DUAL-SIGNALLING PATHWAY AS TARGET FOR SCREENING ANTI-TUMOUR DRUG AND CONSTRUCTION AND USE THEREOF

机译:基于STAT3和NF- DB双信号通路的细胞模型作为筛选抗肿瘤药物及其构建和使用的目标。

摘要

Provided is a cell model based on a STAT3 and NF-κB dual-signaling pathway as the target for high-throughput anti-tumour drugs screening. The model is constructed by employing a STAT3-specific binding sequence and an NF-κB-specific binding sequence to establish a reporter-system vector being then combined with an active cell which has constitutive STAT3 and NF-κB simultaneously.
机译:提供了一种基于STAT3和NF-κB双信号通路的细胞模型,作为高通量抗肿瘤药物筛选的目标。该模型是通过使用STAT3特异性结合序列和NF-κB特异性结合序列建立的,建立一个报告系统载体,然后将其与同时具有组成型STAT3和NF-κB的活性细胞结合。

著录项

  • 公开/公告号WO2013087033A1

    专利类型

  • 公开/公告日2013-06-20

    原文格式PDF

  • 申请/专利权人 LANZHOU UNIVERSITY;

    申请/专利号WO2012CN86710

  • 发明设计人 YANG JINBO;WANG QIN;DU YUPING;CHEN XING;

    申请日2012-12-15

  • 分类号C12N5/10;C12N15/63;C12N15/11;

  • 国家 WO

  • 入库时间 2022-08-21 16:32:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号